
Fairchem Organics (FAIRCHEMOR) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.2B
Gross Profit
264.7M
21.92%
Operating Income
17.8M
1.47%
Net Income
5.9M
0.49%
Balance Sheet Metrics
Total Assets
4.0B
Total Liabilities
998.0M
Shareholders Equity
3.0B
Debt to Equity
0.33
Cash Flow Metrics
Operating Cash Flow
-57.3M
Free Cash Flow
-32.1M
Revenue & Profitability Trend
Fairchem Organics Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 5.4B | 6.2B | 6.5B | 6.4B | 4.0B |
Cost of Goods Sold | 4.0B | 5.1B | 5.3B | 5.0B | 2.9B |
Gross Profit | 1.4B | 1.1B | 1.1B | 1.4B | 1.0B |
Gross Margin % | 25.3% | 18.3% | 17.5% | 22.0% | 26.3% |
Operating Expenses | |||||
Research & Development | - | 4.3M | 4.5M | 4.1M | 5.9M |
Selling, General & Administrative | - | 117.7M | 101.2M | 93.6M | 129.8M |
Other Operating Expenses | 695.9M | 110.1M | 96.6M | 78.3M | 46.2M |
Total Operating Expenses | 695.9M | 232.1M | 202.3M | 176.0M | 181.9M |
Operating Income | 322.5M | 577.0M | 642.2M | 978.2M | 622.7M |
Operating Margin % | 6.0% | 9.3% | 9.9% | 15.2% | 15.7% |
Non-Operating Items | |||||
Interest Income | - | 423.0K | 124.0K | 373.0K | 2.3M |
Interest Expense | 36.7M | 42.4M | 62.6M | 68.6M | 69.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 299.2M | 546.0M | 585.9M | 912.4M | 555.6M |
Income Tax | 79.5M | 141.0M | 150.9M | 233.3M | 130.8M |
Effective Tax Rate % | 26.6% | 25.8% | 25.8% | 25.6% | 23.5% |
Net Income | 219.7M | 405.0M | 435.0M | 679.1M | 424.8M |
Net Margin % | 4.1% | 6.6% | 6.7% | 10.6% | 10.7% |
Key Metrics | |||||
EBITDA | 441.2M | 680.8M | 730.5M | 1.1B | 690.7M |
EPS (Basic) | ₹16.88 | ₹31.10 | ₹33.41 | ₹52.15 | ₹32.63 |
EPS (Diluted) | ₹16.88 | ₹31.10 | ₹33.41 | ₹52.15 | ₹32.63 |
Basic Shares Outstanding | 13017950 | 13020902 | 13020902 | 13020902 | 13020902 |
Diluted Shares Outstanding | 13017950 | 13020902 | 13020902 | 13020902 | 13020902 |
Income Statement Trend
Fairchem Organics Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 82.0K | 84.0K | 78.0K | 83.0K | 260.0K |
Short-term Investments | 12.9M | 1.1M | 760.0K | 1.6M | 200.0K |
Accounts Receivable | 861.3M | 568.1M | 625.8M | 622.2M | 467.7M |
Inventory | 883.1M | 697.0M | 799.6M | 700.3M | 452.9M |
Other Current Assets | 48.3M | 62.1M | 59.4M | 48.2M | 60.0K |
Total Current Assets | 1.8B | 1.3B | 1.5B | 1.4B | 978.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 2.0B | 51.1M | 50.7M | 40.3M | 40.1M |
Goodwill | 1.6M | 3.5M | 5.2M | 2.5M | 477.0K |
Intangible Assets | - | 3.5M | 5.2M | 2.5M | 477.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 13.1M | 21.3M | 13.0K | 19.6M | 29.9M |
Total Non-Current Assets | 2.2B | 2.0B | 1.9B | 1.9B | 1.6B |
Total Assets | 4.0B | 3.3B | 3.4B | 3.2B | 2.6B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 83.4M | 130.2M | 105.7M | 90.5M | 109.1M |
Short-term Debt | 630.3M | 73.2M | 501.7M | 520.4M | 308.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 41.7M | 9.5M | 6.6M | 6.8M | 24.1M |
Total Current Liabilities | 785.6M | 260.7M | 667.8M | 673.8M | 507.6M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | 0 | 99.9M | 259.8M |
Deferred Tax Liabilities | 187.3M | 161.2M | 145.8M | 128.1M | 113.5M |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 212.4M | 183.1M | 163.7M | 245.4M | 391.0M |
Total Liabilities | 998.0M | 443.8M | 831.5M | 919.3M | 898.7M |
Equity | |||||
Common Stock | 130.2M | 130.2M | 130.2M | 130.2M | 130.2M |
Retained Earnings | - | 1.9B | 1.6B | 1.3B | 661.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 3.0B | 2.9B | 2.6B | 2.3B | 1.7B |
Key Metrics | |||||
Total Debt | 630.3M | 73.2M | 501.7M | 620.3M | 568.0M |
Working Capital | 1.0B | 1.1B | 818.0M | 698.6M | 470.7M |
Balance Sheet Composition
Fairchem Organics Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 299.2M | 546.0M | 585.9M | 912.4M | 555.6M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -466.9M | 165.3M | -116.9M | -403.2M | -212.4M |
Operating Cash Flow | -131.6M | 753.3M | 531.6M | 577.4M | 410.7M |
Investing Activities | |||||
Capital Expenditures | -255.7M | -176.6M | -145.0M | -342.2M | -230.4M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -255.7M | -176.6M | -145.0M | -342.2M | -230.4M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -97.7M | -97.7M | -169.3M | -45.6M | - |
Debt Issuance | - | - | - | 0 | 210.7M |
Debt Repayment | - | 0 | -129.2M | -216.5M | -88.0M |
Financing Cash Flow | 459.5M | -526.2M | -287.9M | 6.7M | -98.7M |
Free Cash Flow | -428.9M | 563.5M | 348.9M | 58.9M | 164.6M |
Net Change in Cash | 72.2M | 50.5M | 98.7M | 241.9M | 81.6M |
Cash Flow Trend
Fairchem Organics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
50.61
Price to Book
3.68
Price to Sales
2.07
PEG Ratio
-1.11
Profitability Ratios
Profit Margin
4.09%
Operating Margin
1.44%
Return on Equity
7.42%
Return on Assets
5.47%
Financial Health
Current Ratio
2.30
Debt to Equity
20.87
Beta
-0.07
Per Share Data
EPS (TTM)
₹16.86
Book Value per Share
₹231.96
Revenue per Share
₹413.10
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
fairchemor | 11.1B | 50.61 | 3.68 | 7.42% | 4.09% | 20.87 |
Asian Paints | 2.4T | 65.93 | 12.25 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.77 | 16.03 | 20.85% | 16.16% | 4.56 |
Balaji Amines | 49.9B | 32.81 | 2.71 | 7.80% | 11.11% | 0.55 |
Camlin Fine Sciences | 40.4B | 57.31 | 4.48 | -15.89% | -6.73% | 77.88 |
Grauer & Weil | 43.7B | 27.77 | 4.65 | 18.02% | 13.85% | 1.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.